Mounjaro: FDA Approves GLP-1 for Cardiovascular Risk Reduction
Mounjaro: FDA Approves GLP-1 for Cardiovascular Risk Reduction Healthline
September 2026
FDA approves Zimrixby (rituximab) and Garzulys (insulin aspart) biosimilars
FDA approves Zimrixby (rituximab) and Garzulys (insulin aspart) biosimilars Generics and Biosimilars Initiative
UniQure, after setbacks, seeks FDA approval of Huntington’s gene therapy
UniQure, after setbacks, seeks FDA approval of Huntington’s gene therapy BioPharma Dive
FDA Approves Updated COVID-19 Vaccines for 2026-2027 – respiratory
FDA Approves Updated COVID-19 Vaccines for 2026-2027 respiratory-therapy.com
FDA Approval of Essential Thrombocythemia Drug is “Important Milestone”
FDA Approval of Essential Thrombocythemia Drug is “Important Milestone” CancerNetwork